1. Home
  2. BDSX vs LGI Comparison

BDSX vs LGI Comparison

Compare BDSX & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • LGI
  • Stock Information
  • Founded
  • BDSX 2005
  • LGI 2004
  • Country
  • BDSX United States
  • LGI United States
  • Employees
  • BDSX N/A
  • LGI N/A
  • Industry
  • BDSX Precision Instruments
  • LGI
  • Sector
  • BDSX Health Care
  • LGI
  • Exchange
  • BDSX Nasdaq
  • LGI Nasdaq
  • Market Cap
  • BDSX 194.9M
  • LGI 219.9M
  • IPO Year
  • BDSX 2020
  • LGI N/A
  • Fundamental
  • Price
  • BDSX $1.51
  • LGI $16.05
  • Analyst Decision
  • BDSX Strong Buy
  • LGI
  • Analyst Count
  • BDSX 4
  • LGI 0
  • Target Price
  • BDSX $3.08
  • LGI N/A
  • AVG Volume (30 Days)
  • BDSX 332.5K
  • LGI 41.1K
  • Earning Date
  • BDSX 11-01-2024
  • LGI 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • LGI 7.10%
  • EPS Growth
  • BDSX N/A
  • LGI N/A
  • EPS
  • BDSX N/A
  • LGI N/A
  • Revenue
  • BDSX $65,562,000.00
  • LGI N/A
  • Revenue This Year
  • BDSX $46.97
  • LGI N/A
  • Revenue Next Year
  • BDSX $30.43
  • LGI N/A
  • P/E Ratio
  • BDSX N/A
  • LGI N/A
  • Revenue Growth
  • BDSX 48.92
  • LGI N/A
  • 52 Week Low
  • BDSX $1.11
  • LGI $12.66
  • 52 Week High
  • BDSX $2.21
  • LGI $16.68
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 48.94
  • LGI 28.77
  • Support Level
  • BDSX $1.24
  • LGI $15.75
  • Resistance Level
  • BDSX $1.43
  • LGI $16.74
  • Average True Range (ATR)
  • BDSX 0.10
  • LGI 0.22
  • MACD
  • BDSX 0.01
  • LGI -0.10
  • Stochastic Oscillator
  • BDSX 64.44
  • LGI 6.93

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About LGI Lazard Global Total Return and Income Fund

Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt, and others.

Share on Social Networks: